» Articles » PMID: 2842359

Inhibition of Sex Hormone-binding Globulin Production in the Human Hepatoma (Hep G2) Cell Line by Insulin and Prolactin

Overview
Specialty Endocrinology
Date 1988 Sep 1
PMID 2842359
Citations 137
Authors
Affiliations
Soon will be listed here.
Abstract

Sex hormone-binding globulin (SHBG) production in humans has been thought to be stimulated by estrogens and thyroid hormone and inhibited by androgens. However, recent data indicate that SHBG production in vitro is stimulated by both androgens and estrogens. This study was designed to determine what other hormonal factors regulate SHBG production. Since hyperinsulinemia and hyperprolactinemia both occur in disease states in which low serum SHBG levels are found, the effects of insulin and PRL were compared to and/or studied in combination with estradiol (E2), T4, and testosterone (T) in a human hepatoma cell line (Hep G2). Hep G2 cells were grown to near confluence in medium including 10% fetal calf serum, and then 72-h experimental incubations were carried out which used only fetal calf serum-free medium. Compared to control incubations, both insulin (10(-8) mol/L) and PRL (10(-8) mol/L) decreased SHBG production from 65.0 +/- 0.6 (+/- SE) to 46.8 +/- 1.1 and 46.8 +/- 1.2 nmol/10(6) cells, respectively (P less than 0.01). Insulin also inhibited both E2 and T4-stimulated SHBG production. T stimulated SHBG production to the same degree as E2. Finally, both E2 and insulin significantly increased cell number, an important consideration when expressing the effect of a hormone on SHBG production in cultured cells. We conclude that insulin and PRL inhibit SHBG production and confirm that T4, T, and E2 stimulate SHBG production in vitro. These findings suggest that insulin and PRL may be important factors in the regulation of SHBG production in vivo.

Citing Articles

Fecal propionate is a signature of insulin resistance in polycystic ovary syndrome.

Dong S, Yao X, Jiao J, Lin B, Yan F, Wang X Front Cell Infect Microbiol. 2025; 14:1394873.

PMID: 39872943 PMC: 11769941. DOI: 10.3389/fcimb.2024.1394873.


Changes in Prolactin and Insulin Resistance in PCOS Patients Undergoing Metformin Treatment: A Retrospective Study.

Goldstein T, Ott J, Katzensteiner P, Krysiak R, Marculescu R, Boegl M J Clin Med. 2025; 13(24.

PMID: 39768704 PMC: 11727681. DOI: 10.3390/jcm13247781.


Dietary Patterns and Fertility.

Cristodoro M, Zambella E, Fietta I, Inversetti A, Di Simone N Biology (Basel). 2024; 13(2).

PMID: 38392349 PMC: 10886842. DOI: 10.3390/biology13020131.


SHBG Levels Do Not Correlate with Insulin Levels in PCOS with Appropriate Fasting Insulin Sensitivity.

Tuu L, Nas K, Torok M, Varbiro S J Clin Med. 2024; 13(3).

PMID: 38337532 PMC: 10856642. DOI: 10.3390/jcm13030838.


Reproductive risk factors across the female lifecourse and later metabolic health.

Nichols A, Chavarro J, Oken E Cell Metab. 2024; 36(2):240-262.

PMID: 38280383 PMC: 10871592. DOI: 10.1016/j.cmet.2024.01.002.